NCT02825238 is a NA clinical trial of Supervised exercise program in Patellofemoral Osteoarthritis, sponsored by University of the Sciences in Philadelphia.

Who is sponsoring NCT02825238?

NCT02825238 is sponsored by University of the Sciences in Philadelphia.

What drugs are being tested in NCT02825238?

Interventions in NCT02825238: Supervised exercise program.

What condition does NCT02825238 study?

NCT02825238 studies Patellofemoral Osteoarthritis.

Is NCT02825238 still recruiting?

NCT02825238 is currently completed. Last updated 8 May 2018.

Last reviewed 2018-05-08 · How we verify

NCT02825238

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Hip and Core Muscle Strengthening for Patellofemoral Osteoarthritis: A Feasibility Study

Completed NA Last updated 8 May 2018

What this trial tests

NA trial testing Supervised exercise program in Patellofemoral Osteoarthritis in 20 participants. Completed in 11 December 2015.

Timeline

23 October 2012

Primary endpoint
11 December 2015

11 December 2015

Quick facts

Lead sponsor	University of the Sciences in Philadelphia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	23 October 2012
Primary completion	11 December 2015
Estimated completion	11 December 2015
Sites	2 locations across United States

Drugs / interventions tested

Supervised exercise program

Conditions studied

Patellofemoral Osteoarthritis — all drugs for Patellofemoral Osteoarthritis →

Sponsor

University of the Sciences in Philadelphia

Who can join

Adults 35 to 70, any sex, with Patellofemoral Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to develop and test the feasibility of an exercise intervention for persons with painful knee osteoarthritis involving the patella (kneecap). Participants in the patellofemoral osteoarthritis (PFOA) group will be treated with a 6-week supervised exercise program that targets strengthening the hip and trunk core muscles. Painfree control participants will attend one session to gather biomechanical, strength, and function data for use in comparison to the patellofemoral osteoarthritis group. Feasibility outcomes include adherence to the treatment program, recruitment, and retention. It is hypothesized that PFOA group participants will change score on a knee pain and function questionnaire by the minimum clinically important difference score for positive improvement at the end of the 6-week intervention program.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A 6-week hip muscle strengthening and lumbopelvic-hip core stabilization program to improve pain, function, and quality of life in persons with patellofemoral osteoarthritis: a feasibility pilot study.
Hoglund LT, Pontiggia L, Kelly JD. · · 2018 · cited 12× · PMID 29636983 · DOI 10.1186/s40814-018-0262-z

Verify or expand the search:

Other trials of Supervised exercise program

Trials testing the same drug.

NCT07454616 — Exploratory Study on a Multi-nutrient Supplement and Exercise Program for Improving Health Markers Associated to Longevi · NA · recruiting
NCT05266352 — Investigation of the Effect of Exercise Training on Psychosocial Outcomes in Rotator Cuff Tears · NA · completed
NCT03420196 — Efficacy of a Supervised Physical Therapy Rehabilitation Program vs Nonsupervised in Non-specific Low Back Pain · NA · completed

Other recruiting trials for Patellofemoral Osteoarthritis

Currently open trials in the same condition.

NCT04772625 — Failure Analysis of Patellofemoral Arthroplasty · active not recruiting

Other University of the Sciences in Philadelphia trials

Trials by the same sponsor.

NCT05253092 — The Effects of Mindfulness Meditation on Sleep Quality and Perceived Stress · NA · completed
NCT03784053 — Virtual Reality and Occupational Performance, Satisfaction, and Quality of Life of Older Adults · unknown
NCT03964467 — Priming With tDCS: Expanding the Window of Recovery in Chronic Stroke · NA · unknown
NCT03170492 — Does Computerized Cognitive Training Improve Executive Functioning in the Older Adult? · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02825238 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of the Sciences in Philadelphia
Last refreshed: 8 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02825238.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing